JP2005528359A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005528359A5 JP2005528359A5 JP2003577780A JP2003577780A JP2005528359A5 JP 2005528359 A5 JP2005528359 A5 JP 2005528359A5 JP 2003577780 A JP2003577780 A JP 2003577780A JP 2003577780 A JP2003577780 A JP 2003577780A JP 2005528359 A5 JP2005528359 A5 JP 2005528359A5
- Authority
- JP
- Japan
- Prior art keywords
- transdermal
- depression
- dosage
- buprenorphine
- transdermal dosage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 claims 6
- RMRJXGBAOAMLHD-IHFGGWKQSA-N buprenorphine Chemical compound C([C@]12[C@H]3OC=4C(O)=CC=C(C2=4)C[C@@H]2[C@]11CC[C@]3([C@H](C1)[C@](C)(O)C(C)(C)C)OC)CN2CC1CC1 RMRJXGBAOAMLHD-IHFGGWKQSA-N 0.000 claims 3
- 229960001736 buprenorphine Drugs 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 2
- 208000024891 symptom Diseases 0.000 claims 2
- 239000006211 transdermal dosage form Substances 0.000 claims 2
- 238000009792 diffusion process Methods 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 239000006210 lotion Substances 0.000 claims 1
- 239000002674 ointment Substances 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
- 229940100640 transdermal system Drugs 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36635802P | 2002-03-20 | 2002-03-20 | |
| PCT/US2003/008796 WO2003079945A1 (en) | 2002-03-20 | 2003-03-20 | Method of administering buprenorphine to treat depression |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005528359A JP2005528359A (ja) | 2005-09-22 |
| JP2005528359A5 true JP2005528359A5 (https=) | 2006-05-11 |
Family
ID=28454789
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003577780A Pending JP2005528359A (ja) | 2002-03-20 | 2003-03-20 | うつ病の治療のためのブプレノルフィンの投与方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20030181475A1 (https=) |
| EP (1) | EP1485051B1 (https=) |
| JP (1) | JP2005528359A (https=) |
| AT (1) | ATE394097T1 (https=) |
| AU (1) | AU2003224742A1 (https=) |
| CY (1) | CY1108217T1 (https=) |
| DE (1) | DE60320770D1 (https=) |
| DK (1) | DK1485051T3 (https=) |
| ES (1) | ES2305457T3 (https=) |
| PT (1) | PT1485051E (https=) |
| SI (1) | SI1485051T1 (https=) |
| WO (1) | WO2003079945A1 (https=) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5968547A (en) | 1997-02-24 | 1999-10-19 | Euro-Celtique, S.A. | Method of providing sustained analgesia with buprenorphine |
| DK1572167T3 (da) | 2002-12-13 | 2008-10-13 | Euro Celtique Sa | Transdermal buprenophindoseringsbehandlingsplan for analgesi |
| EP1913938A1 (en) * | 2002-12-13 | 2008-04-23 | Euro-Celtique S.A. | Transdermal buprenorphine dosage regimen for analgesia |
| RS20050812A (sr) | 2003-04-30 | 2007-12-31 | Purdue Pharma L.P., | Transdermalni dozni oblik otporan na promene |
| US8790689B2 (en) | 2003-04-30 | 2014-07-29 | Purdue Pharma L.P. | Tamper resistant transdermal dosage form |
| ATE375149T1 (de) | 2003-07-25 | 2007-10-15 | Euro Celtique Sa | Behandlung von entzug |
| DE10340428B4 (de) * | 2003-09-02 | 2015-02-12 | Acino Ag | Opioides Analgetikum enthaltende transdermale Formulierung |
| FR2865650B1 (fr) * | 2004-01-30 | 2008-06-13 | Biocortech | Utilisation du 14,15 dihydro 20,21-dinoreburnamenin14-ol pour traiter et/ou prevenir les depressions majeures et les desordres du cycle veille-sommeil |
| DE102004045599A1 (de) * | 2004-09-17 | 2006-03-23 | Grünenthal GmbH | System zur sequentiellen, transdermalen Verabreichung von systemisch wirksamen Substanzen |
| DE102005007859A1 (de) * | 2005-02-21 | 2006-08-24 | Lts Lohmann Therapie-Systeme Ag | Vefahren für eine medikamentöse Kombinations-Behandlung, sowie hierfür geeignete Arzneimittel-Kombinationen |
| DE102006011340A1 (de) * | 2006-03-09 | 2007-09-20 | Grünenthal GmbH | Wirkstoffhaltige Pflaster mit verbesserter Handhabung |
| US9119848B2 (en) | 2009-12-04 | 2015-09-01 | Alkermes Pharma Ireland Limited | Morphinan derivatives for the treatment of drug overdose |
| HUE065427T2 (hu) | 2010-08-23 | 2024-05-28 | Alkermes Pharma Ireland Ltd | Eljárások antipszichotikum által indukált súlygyarapodás kezelésére |
| WO2013042054A1 (en) * | 2011-09-19 | 2013-03-28 | Carmel - Haifa University Economic Corporation Ltd. | Buprenorphine for the treatment of acute suicidality |
| US9211293B2 (en) | 2011-12-15 | 2015-12-15 | Alkermes Pharma Ireland Limited | Opioid agonist antagonist combinations |
| EP2790703B1 (en) * | 2011-12-15 | 2019-06-12 | Alkermes Pharma Ireland Limited | Samidorphan (alks 33) in combination with opioid agonists |
| US10195191B2 (en) | 2011-12-15 | 2019-02-05 | Alkermes Pharma Ireland Limited | Opioid agonist antagonist combinations |
| MX375348B (es) * | 2011-12-15 | 2025-03-06 | Alkermes Pharma Ireland Ltd | Composiciones de la buprenorfina y antagonistas de los receptores opioide-mu. |
| EP3003311A2 (en) | 2013-05-24 | 2016-04-13 | Alkermes Pharma Ireland Limited | Methods for treating depressive symptoms |
| CA2911231C (en) | 2013-05-24 | 2021-12-07 | Alkermes Pharma Ireland Limited | Morphan and morphinan analogues, and methods of use |
| MX368870B (es) * | 2013-12-20 | 2019-10-21 | H Lundbeck As | Uso de un antagonista de receptores de opioides con actividad kappa y vortioxetina para el tratamiento de trastorno depresivo con características melancólicas. |
| WO2022101444A1 (en) | 2020-11-12 | 2022-05-19 | Alkermes Pharma Ireland Limited | Immediate release multilayer tablet |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4806341A (en) * | 1985-02-25 | 1989-02-21 | Rutgers, The State University Of New Jersey | Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration |
| US5026556A (en) * | 1988-11-10 | 1991-06-25 | Norwich Eaton Pharmaceuticals, Inc. | Compositions for the transdermal delivery of pharmaceutical actives |
| US4956171A (en) * | 1989-07-21 | 1990-09-11 | Paco Pharmaceutical Services, Inc. | Transdermal drug delivery using a dual permeation enhancer and method of performing the same |
| US5240711A (en) * | 1989-11-29 | 1993-08-31 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Transdermal therapeutic system comprising as active component buprenorphine |
| EP0484543B1 (en) * | 1990-04-24 | 1995-12-13 | Teijin Limited | Plaster |
| US5069909A (en) * | 1990-06-20 | 1991-12-03 | Cygnus Therapeutic Systems | Transdermal administration of buprenorphine |
| US5512593A (en) * | 1993-03-02 | 1996-04-30 | John S. Nagle | Composition and method of treating depression using natoxone or naltrexone in combination with a serotonin reuptake inhibitor |
| US5613958A (en) * | 1993-05-12 | 1997-03-25 | Pp Holdings Inc. | Transdermal delivery systems for the modulated administration of drugs |
| JP4086317B2 (ja) * | 1996-03-25 | 2008-05-14 | エルティエス ローマン テラピー―ズュステーメ アーゲー | 塗布領域の厚さが薄く柔軟性が高い経皮治療システムおよびその製造方法 |
| US6787149B1 (en) * | 1996-12-12 | 2004-09-07 | El Khoury And Stein Ltd. | Topical application of opioid analgesic drugs such as morphine |
| US5968547A (en) * | 1997-02-24 | 1999-10-19 | Euro-Celtique, S.A. | Method of providing sustained analgesia with buprenorphine |
| US5900420A (en) * | 1997-06-19 | 1999-05-04 | Cole; William L. | Method for treating chronic fatigue syndrome and fibromyalgia with buprenorphine |
| DE19738855C2 (de) * | 1997-09-05 | 2001-01-04 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit haftklebender Reservoirschicht und unidirektional elastischer Rückschicht |
| DE19746191C2 (de) * | 1997-10-18 | 2000-05-18 | Lohmann Therapie Syst Lts | Verfahren zur Anwendung eines Wirkstoff enthaltenden Pflasters zur Bekämpfung oder Linderung einer Sucht |
| EP1061924A1 (en) * | 1998-03-09 | 2000-12-27 | Trustees Of Tufts College | Treatment of compulsive behaviours in man and animals |
| DE19840758A1 (de) * | 1998-09-07 | 2000-03-09 | Liedtke Pharmed Gmbh | Systemische Therapie von Schmerz- und depressiver Befindlichkeit |
-
2003
- 2003-03-20 AU AU2003224742A patent/AU2003224742A1/en not_active Abandoned
- 2003-03-20 AT AT03721427T patent/ATE394097T1/de active
- 2003-03-20 DE DE60320770T patent/DE60320770D1/de not_active Expired - Lifetime
- 2003-03-20 SI SI200331272T patent/SI1485051T1/sl unknown
- 2003-03-20 EP EP03721427A patent/EP1485051B1/en not_active Expired - Lifetime
- 2003-03-20 US US10/394,425 patent/US20030181475A1/en not_active Abandoned
- 2003-03-20 JP JP2003577780A patent/JP2005528359A/ja active Pending
- 2003-03-20 DK DK03721427T patent/DK1485051T3/da active
- 2003-03-20 PT PT03721427T patent/PT1485051E/pt unknown
- 2003-03-20 ES ES03721427T patent/ES2305457T3/es not_active Expired - Lifetime
- 2003-03-20 WO PCT/US2003/008796 patent/WO2003079945A1/en not_active Ceased
-
2008
- 2008-07-28 CY CY20081100780T patent/CY1108217T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005528359A5 (https=) | ||
| DE69826644D1 (de) | Topische pharmazeutische zusammensetzung, enthaltend einen cholinergischen wirkstoff oder einen kalziumkanalblocker | |
| JP2011252020A5 (https=) | ||
| WO2001082914A3 (en) | Topical anesthetic/opioid formulations and uses thereof | |
| NO20001175D0 (no) | Smertestillende blandinger omfattende anti-epileptiske forbindelser og fremgangsmÕter for anvendelse derav | |
| JP2009544619A5 (https=) | ||
| UA88464C2 (ru) | Способ дермального введения метадоновой композиции с обеспечением системного действия | |
| DE60034667D1 (de) | Pharmazeutische zusammensetzung aus komplexen kohlenhydraten deren anwendung | |
| NZ592039A (en) | Combination therapy for the treatment of ocular neovascular disorders | |
| CY1108217T1 (el) | Μεθοδος χορηγησης βουπρενορφινης για τη θεραπεια της καταθλιψης | |
| WO2007012019A3 (en) | Medicaments containing famotidine and ibuprofen and administration of same | |
| CA2530005A1 (en) | Use of buprenorphine for the treatment of drug dependence withdrawal in a pregnant woman | |
| JP2006513184A5 (https=) | ||
| DK1572167T3 (da) | Transdermal buprenophindoseringsbehandlingsplan for analgesi | |
| AU5706301A (en) | Topical formulations for the transdermal delivery of niacin and methods of treating hyperlipidemia | |
| IL167890A (en) | Use of a chorionic gonadotropin in the preparation of a medicament for treating a chronic pelvic pain syndrome | |
| RU2002103808A (ru) | Способ лечения болевого синдрома у онкологических больных | |
| WO2003059284A3 (en) | Composition and method for inhibiting hypersensitivity | |
| BR0313305A (pt) | Agente analgésico para indivìduos recém-nascidos ou fetais | |
| WO2006117404A3 (de) | Topische verwendung von radikalfangenden substanzen zur antipyretischen behandlung | |
| Giusti et al. | Alternative Routes for Systemic Opioid Delivery | |
| DE60012575D1 (de) | Nsaid enthaltendes wasserfreies gel zur topischen anwendung in der mundhöhle | |
| HK1203365A1 (en) | Transmucosal drug delivery devices for use in chronic pain relief | |
| RU2007106415A (ru) | Способ лечения тяжелой формы вульгарных угрей | |
| RU2003115786A (ru) | Способ лечения пневмонии у новорожденных |